Leading oncology company Incanthera has launched a partnership with global investment group Technomark Life Sciences. The two businesses will work together to prepare ICT2588 - Incanthera’s revolutionary treatment for solid tumours ...
Tags: Life Sciences, clinical trials, medical
Acceleron Pharma has announced that the Gynecologic Oncology Group (GOG) has sponsored its phase 2 study of dalantercept. Patients with persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer are taking part in the ...
Pharmaceutical and biotech companies are outsourcing research in order to develop innovative products that meet the rising demand for therapeutics across a range of diseases. The willingness of contract research organisations (CROs) to ...
Tags: Pharmaceutical, CROs, innovative products
US-based biopharmaceutical company Hyperion Therapeutics has announced that it has gained approval from US Food and Drug Administration (FDA) for its RAVICTI (glycerol phenylbutyrate) liquid drug. RAVICTI used for treating Urea Cycle ...
Tags: FDA, drug, biopharmaceutical company
Computer Service Partners is proud to announce that Patrick Spampinato has recently joined the team as a new Virtual CIO. He will be focused on designing IT solutions that align with CSP clients' corporate strategic initiatives. He is ...
If you suffer from overactive bladder you now have two new options: Botox injections (yes, the wrinkle-shrinking drug), and an over-the-counter version of the Oxytrol patch, which used to require a prescription. The Food and Drug ...
Tags: overactive bladder, Botox injections, healthcare, medical tips
US-based SPR Therapeutics has obtained CE mark for its peripheral nerve stimulation (PNS) device, Smartpatch system, designed for the minimally-invasive treatment of chronic shoulder pain. The non-narcotic, reversible system stimulates ...
Tags: Therapeutics Smartpatch system, minimally invasive treatment
Clinical research and service provider GeneDiagnostics has entered into an agreement to distribute WILEX's serum HER-2/neu ELISA test in China. The FDA-approved and CE-marked biomarker test measures serum HER-2/neu protein levels and ...
Tags: Clinical research, GeneDiagnostics, WILEX, serum HER-2/neu ELISA test
The United States Patent and Trademark Office has issued a patent covering the methods of cancer treatment with Lorus Therapeutics' novel therapy, IL-17E. Treatment methods with IL-17E include single and combination therapy along with ...
Tags: IL-17E, Lorus Therapeutics, Cancer Therapy, US Patent
Clinical research software and services provider Nextrials will showcase its clinical trial management solution at the annual IHE North America Connectathon, which will be held from 28 January - 2 February 2013 at Hyatt Regency Chicago, US. ...
Tags: clinical trial, Clinical Research Document, Drug Safety Content
Oncology patients with lower income are substantially less likely to take part in clinical trials, it has been suggested. Research published in the January 7th Journal of Clinical Oncology looked at clinical trial participation patterns, ...
Tags: Oncology, patients, lower income, clinical trials
LGC and Quotient Bioresearch have reached agreement on the sale by Quotient of its Bioanalytical Sciences division, which now forms part of LGC's Health Sciences division. The acquisition will enable LGC to provide an enhanced range of ...
Tags: LGC, bioanalytical sciences business, Bioanalytical Sciences division
Manufacturers who want to keep selling all-metal hips will have to prove that they're safe and effective, according to proposed new rules from the Food and Drug Administration. Incredibly, for the past decade manufacturers have been ...
Tags: all-metal hips, healthcare, hip implants
MRC Technology, a technology transfer charity and company, announced at the end of last year a pound 577,000 funding award from the Biomedical Catalyst. The award has been granted to MRC Technology to fund research into the role of ...
Multinational pharmaceutical and diagnostics company OPKO Health has signed a definitive agreement to acquire Cytochroma. Under the purchase, OPKO intends to include Cytochroma's Replidea and Alpharen, which are in Phase 3 clinical trials ...
Tags: OPKO Health, Cytochroma, CKD, pharmaceutical